WO2021085550A1 - 含フッ素ピリミジン化合物およびその製造方法 - Google Patents
含フッ素ピリミジン化合物およびその製造方法 Download PDFInfo
- Publication number
- WO2021085550A1 WO2021085550A1 PCT/JP2020/040682 JP2020040682W WO2021085550A1 WO 2021085550 A1 WO2021085550 A1 WO 2021085550A1 JP 2020040682 W JP2020040682 W JP 2020040682W WO 2021085550 A1 WO2021085550 A1 WO 2021085550A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- carbon atoms
- hydrocarbon group
- following general
- Prior art date
Links
- -1 Fluorinated pyrimidine compound Chemical class 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title claims description 43
- 238000000034 method Methods 0.000 title claims description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 46
- 125000005843 halogen group Chemical group 0.000 claims abstract description 30
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 22
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 16
- 150000001875 compounds Chemical class 0.000 claims description 95
- 125000004432 carbon atom Chemical group C* 0.000 claims description 83
- 229910052731 fluorine Inorganic materials 0.000 claims description 59
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 55
- 239000011737 fluorine Substances 0.000 claims description 55
- 150000003839 salts Chemical class 0.000 claims description 25
- 125000005620 boronic acid group Chemical group 0.000 claims description 19
- GRLHOORFDPGKMC-UHFFFAOYSA-N 1-fluoro-2-methylprop-1-ene Chemical group CC(C)=CF GRLHOORFDPGKMC-UHFFFAOYSA-N 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract description 4
- 125000005619 boric acid group Chemical group 0.000 abstract 2
- 150000002430 hydrocarbons Chemical group 0.000 description 63
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 51
- 238000006243 chemical reaction Methods 0.000 description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 25
- FSDLLONBRLBIBL-UHFFFAOYSA-N 1,3,3,3-tetrafluoro-1-methoxy-2-(trifluoromethyl)prop-1-ene Chemical compound COC(F)=C(C(F)(F)F)C(F)(F)F FSDLLONBRLBIBL-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 21
- 125000001424 substituent group Chemical group 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 238000001819 mass spectrum Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 125000000714 pyrimidinyl group Chemical group 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 238000003756 stirring Methods 0.000 description 15
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 10
- 125000002723 alicyclic group Chemical group 0.000 description 7
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- 0 *OC(F)=C(C(F)(F)F)C(F)(F)F Chemical compound *OC(F)=C(C(F)(F)F)C(F)(F)F 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 150000001721 carbon Chemical group 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 5
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- AQHKYFLVHBIQMS-UHFFFAOYSA-N 2-[difluoro(methoxy)methyl]-1,1,1,3,3,3-hexafluoropropane Chemical compound COC(F)(F)C(C(F)(F)F)C(F)(F)F AQHKYFLVHBIQMS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241000209094 Oryza Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012433 hydrogen halide Substances 0.000 description 4
- 229910000039 hydrogen halide Inorganic materials 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- KSFZMJFKMWUHDF-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=NC=CS2)F)C(F)(F)F Chemical compound COC1=C(C(=NC(=N1)C2=NC=CS2)F)C(F)(F)F KSFZMJFKMWUHDF-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 150000003230 pyrimidines Chemical class 0.000 description 3
- KAVUKAXLXGRUCD-UHFFFAOYSA-M sodium trifluoromethanesulfinate Chemical compound [Na+].[O-]S(=O)C(F)(F)F KAVUKAXLXGRUCD-UHFFFAOYSA-M 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- ZPJZGMWGRAUEAJ-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=CC=CS2)F)C(F)(F)F Chemical compound COC1=C(C(=NC(=N1)C2=CC=CS2)F)C(F)(F)F ZPJZGMWGRAUEAJ-UHFFFAOYSA-N 0.000 description 2
- YHZSTTRMMAERIV-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=CSC=C2)F)C(F)(F)F Chemical compound COC1=C(C(=NC(=N1)C2=CSC=C2)F)C(F)(F)F YHZSTTRMMAERIV-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000002051 biphasic effect Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- URAGJMBGNVOIJC-UHFFFAOYSA-N thiophene-2-carboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CS1 URAGJMBGNVOIJC-UHFFFAOYSA-N 0.000 description 2
- CAUZIIYPBLBRFI-UHFFFAOYSA-N thiophene-3-carboximidamide;hydrochloride Chemical compound Cl.NC(=N)C=1C=CSC=1 CAUZIIYPBLBRFI-UHFFFAOYSA-N 0.000 description 2
- 239000003799 water insoluble solvent Substances 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- MOIIOZOJYWYXEP-UHFFFAOYSA-N 1,3-thiazole-2-carboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=NC=CS1 MOIIOZOJYWYXEP-UHFFFAOYSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical compound C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 description 1
- KNFAXGKJGHWUBB-UHFFFAOYSA-N 2-pyrimidin-2-yl-1,3-thiazole Chemical group C1=CSC(C=2N=CC=CN=2)=N1 KNFAXGKJGHWUBB-UHFFFAOYSA-N 0.000 description 1
- ROZONHXKGSVJFN-UHFFFAOYSA-N 2-thiophen-2-ylpyrimidine Chemical group C1=CSC(C=2N=CC=CN=2)=C1 ROZONHXKGSVJFN-UHFFFAOYSA-N 0.000 description 1
- JSZNHWCHEOFXAY-UHFFFAOYSA-N 2-thiophen-3-ylpyrimidine Chemical group S1C=CC(C=2N=CC=CN=2)=C1 JSZNHWCHEOFXAY-UHFFFAOYSA-N 0.000 description 1
- QDFXRVAOBHEBGJ-UHFFFAOYSA-N 3-(cyclononen-1-yl)-4,5,6,7,8,9-hexahydro-1h-diazonine Chemical compound C1CCCCCCC=C1C1=NNCCCCCC1 QDFXRVAOBHEBGJ-UHFFFAOYSA-N 0.000 description 1
- CHMOXOZMBYAKCO-UHFFFAOYSA-N 4-(cyclodecen-1-yl)-2-methyl-5,6,7,8,9,10-hexahydro-1h-triazecine Chemical compound CN1NCCCCCCC(C=2CCCCCCCCC=2)=N1 CHMOXOZMBYAKCO-UHFFFAOYSA-N 0.000 description 1
- JAAWHROJHURLSG-UHFFFAOYSA-N 5-pyrimidin-2-yl-1,3-thiazole Chemical group S1C=NC=C1C1=NC=CC=N1 JAAWHROJHURLSG-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- GUCBLKVOFPITJN-UHFFFAOYSA-N C1=C(C(=CS1)Br)C(=N)N.Cl Chemical compound C1=C(C(=CS1)Br)C(=N)N.Cl GUCBLKVOFPITJN-UHFFFAOYSA-N 0.000 description 1
- JWFOOGASDWHAEK-UHFFFAOYSA-N C1=CSC(=C1)C2=NC=C(C=N2)C(F)(F)F Chemical group C1=CSC(=C1)C2=NC=C(C=N2)C(F)(F)F JWFOOGASDWHAEK-UHFFFAOYSA-N 0.000 description 1
- IZBGNPFCNXAXCA-UHFFFAOYSA-N CC1=CSC(=N1)C2=NC(=C(C(=N2)F)C(F)(F)F)OC.CC1=CSC(=N1)C(=N)N.Cl Chemical compound CC1=CSC(=N1)C2=NC(=C(C(=N2)F)C(F)(F)F)OC.CC1=CSC(=N1)C(=N)N.Cl IZBGNPFCNXAXCA-UHFFFAOYSA-N 0.000 description 1
- PSGWLRXXASUFBG-UHFFFAOYSA-N CN(C)C1=NC=C(C2=NC(F)=C(C(F)(F)F)C(OC)=N2)S1 Chemical compound CN(C)C1=NC=C(C2=NC(F)=C(C(F)(F)F)C(OC)=N2)S1 PSGWLRXXASUFBG-UHFFFAOYSA-N 0.000 description 1
- GERMCMODIIHRJC-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=CC=C(S2)[N+](=O)[O-])F)C(F)(F)F Chemical compound COC1=C(C(=NC(=N1)C2=CC=C(S2)[N+](=O)[O-])F)C(F)(F)F GERMCMODIIHRJC-UHFFFAOYSA-N 0.000 description 1
- SXQXLGOAODIJFA-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=CN=C(S2)OC)F)C(F)(F)F.COC1=NC=C(S1)C(=N)N.Cl Chemical compound COC1=C(C(=NC(=N1)C2=CN=C(S2)OC)F)C(F)(F)F.COC1=NC=C(S1)C(=N)N.Cl SXQXLGOAODIJFA-UHFFFAOYSA-N 0.000 description 1
- VZOCGIAFAPONSY-UHFFFAOYSA-N COC1=C(C(=NC(=N1)C2=CSC=N2)F)C(F)(F)F.C1=C(N=CS1)C(=N)N.Cl Chemical compound COC1=C(C(=NC(=N1)C2=CSC=N2)F)C(F)(F)F.C1=C(N=CS1)C(=N)N.Cl VZOCGIAFAPONSY-UHFFFAOYSA-N 0.000 description 1
- ZYRZISNFFOWWCV-UHFFFAOYSA-N COC1=NC(C(S2)=CC=C2Cl)=NC(F)=C1C(F)(F)F Chemical compound COC1=NC(C(S2)=CC=C2Cl)=NC(F)=C1C(F)(F)F ZYRZISNFFOWWCV-UHFFFAOYSA-N 0.000 description 1
- CYOGQKBTNNRPLX-UHFFFAOYSA-N COC1=NC(C2=CC=C(SC)S2)=NC(F)=C1C(F)(F)F Chemical compound COC1=NC(C2=CC=C(SC)S2)=NC(F)=C1C(F)(F)F CYOGQKBTNNRPLX-UHFFFAOYSA-N 0.000 description 1
- NSACEBFOMJQCDW-UHFFFAOYSA-N COC1=NC(C2=CSC=C2Br)=NC(F)=C1C(F)(F)F Chemical compound COC1=NC(C2=CSC=C2Br)=NC(F)=C1C(F)(F)F NSACEBFOMJQCDW-UHFFFAOYSA-N 0.000 description 1
- UAOJHJCWPSCOAH-UHFFFAOYSA-N COC1=NC(C2=NC(C(F)(F)F)=CS2)=NC(F)=C1C(F)(F)F Chemical compound COC1=NC(C2=NC(C(F)(F)F)=CS2)=NC(F)=C1C(F)(F)F UAOJHJCWPSCOAH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GKKCNDITLLBBDB-UHFFFAOYSA-N FC(C1=CN=C(C2=CSC=N2)N=C1)(F)F Chemical group FC(C1=CN=C(C2=CSC=N2)N=C1)(F)F GKKCNDITLLBBDB-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 125000005621 boronate group Chemical group 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229940071125 manganese acetate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005071 nonynyl group Chemical group C(#CCCCCCCC)* 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Definitions
- the present invention relates to a fluorine-containing pyrimidine compound and a method for producing the same.
- fluorine-containing pyrimidine compounds have various biological activities.
- a compound having a thiophene ring or a thiazole ring as a substituent at the 2-position of the pyrimidine ring is expected to be used in the fields of pharmaceuticals and agrochemicals.
- Patent Document 1 reports that a compound having a 2- (2-thienyl) -5- (trifluoromethyl) pyrimidine structure has a tubercle bacillus growth inhibitory activity.
- Patent Document 2 reports that a compound having a 2- (2-thienyl) -pyrimidine structure has a drug-resistant influenza A virus growth inhibitory activity.
- Patent Document 3 a compound having a 2- (3-thienyl) -pyrimidine structure is synthesized as an antitumor active compound.
- Patent Documents 4 to 6 compounds having a thiazole ring at the 2-position of the pyrimidine ring are disclosed in Patent Documents 4 to 6.
- Patent Document 4 reports that a compound having a 2- (2-thiazolyl) -pyrimidine structure has antitumor activity against prostate tumors and the like.
- Patent Document 5 reports that a compound having a 2- (4-thiazolyl) -5- (trifluoromethyl) pyrimidine structure has antitumor activity against Burkitt lymphoma.
- Patent Document 6 reports that a compound having a 2- (5-thiazolyl) -pyrimidine structure is effective in treating hypertension, PTSD, depression, pain and the like. From this point of view, there is interest in introducing substituents at the 4- and 6-positions of the pyrimidine ring in anticipation of further improvement in activity.
- Non-Patent Document 1 is a synthetic method using sodium trifluoromethanesulfinate (Langlois reagent)
- Non-Patent Document 2 is a synthetic method using a trifluoroacetic acid derivative
- Non-Patent Document 3 is anhydrous. Synthetic methods using trifluoromethanesulfonic acid have been reported, respectively.
- a fluorine-containing pyrimidine having a fluorine-containing substituent at the 5-position of the pyrimidine ring, a heterocycle as a substituent at the 2-position, and a substituent at the 4-position and the 6-position is difficult, and such a fluorine-containing pyrimidine compound has not been reported.
- the fluorine-containing pyrimidine compound is expected to have various biological activities, and is a novel fluorine-containing pyrimidine compound having a substituent at the 4- and 6-positions of the pyrimidine ring and a heterocycle as a substituent at the 2-position. And its manufacturing method was desired to be established.
- Non-Patent Document 1 since the position selectivity at the time of introducing a trifluoromethyl group is low, a trihomine is used for a substrate having a plurality of heterocycles such as a pyrimidine compound in which a heterocycle is substituted. There is a concern that the introduction efficiency of the fluoromethyl group will decrease or that the introduction of the trifluoromethyl group will be difficult. In addition to using 3 times the amount of Langlois reagent as a trifluoromethylating agent for the substrate, there is also the problem of using 3 times the amount of manganese acetate (III) hydrate, which is harmful as an oxidizing agent, as well as the substrate. there were.
- Non-Patent Documents 2 and 3 it is conceivable that the compound obtained by the production methods reported in Non-Patent Documents 2 and 3 is further modified and derivatized to be converted into the fluorine-containing pyrimidine compound.
- the present inventors have obtained the finding that a thiophene ring structure or a thiazole ring structure can be introduced at the 2-position between two nitrogen atoms on the pyrimidine ring by reacting a specific raw material, and the present invention has been obtained.
- the present invention is a novel fluorine-containing pyrimidine compound having a substituent at the 4- and 6-positions of the pyrimidine ring and a thiophene ring structure or a thiazole ring structure as a substituent at the 2-position, which has not been known conventionally.
- an object of the present invention is to provide a production method capable of easily producing the fluorine-containing pyrimidine compound.
- the gist structure of the present invention is as follows.
- R represents a hydrocarbon group having 1 to 12 carbon atoms.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- a fluorine-containing pyrimidine compound of the following general formula (3) by reacting a fluoroisobutane derivative represented by the following general formula (8) with a compound represented by the following general formula (7) or a salt thereof.
- Q represents a halogen atom, -OA 1 , -SO m A 1 (m is an integer of 0 to 3) or -NA 1 A 2 .
- R represents a hydrocarbon group having 1 to 12 carbon atoms.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- a method for producing a fluorine-containing pyrimidine compound [5] The method for producing a fluorine-containing pyrimidine compound according to [3] or [4], wherein R is an alkyl group having 1 to 10 carbon atoms.
- the fluorine-containing pyrimidine compound in one embodiment is represented by the following general formulas (1), (2) or (3).
- R represents a hydrocarbon group having 1 to 12 carbon atoms.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- R is not particularly limited as long as it is a hydrocarbon group having 1 to 12 carbon atoms and is composed of a carbon atom and a hydrogen atom, and examples thereof include a chain hydrocarbon group, an aromatic hydrocarbon group, and an alicyclic hydrocarbon group. Can be done.
- the chain hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 1 to 12, and may be a linear hydrocarbon group or a branched chain hydrocarbon group.
- R is an aromatic hydrocarbon group
- the aromatic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 6 to 12, and even an aromatic hydrocarbon group having a substituent can be used as a substituent. It may be an aromatic hydrocarbon group that does not have.
- the aromatic hydrocarbon group may have a condensed polycyclic structure.
- R is an alicyclic hydrocarbon group
- the alicyclic hydrocarbon group is not particularly limited as long as the total number of carbon atoms is 3 to 12, and even an alicyclic hydrocarbon group having a substituent may be used. It may be an alicyclic hydrocarbon group having no substituent. Further, the alicyclic hydrocarbon group may have a bridging ring structure.
- chain hydrocarbon group examples include methyl group, ethyl group, n-propyl group, i-propyl group, n-butyl group, i-butyl group, sec-butyl group, ter-butyl group, pentyl group and hexyl group.
- Alkyl groups such as heptyl group, octyl group, nonyl group, decyl group, undecyl group, dodecyl group; Alkenyl groups such as ethenyl group, propenyl group, butenyl group, pentenyl group, hexenyl group, heptenyl group, octenyl group, nonenyl group, decenyl group, undecenyl group, dodecenyl group; Examples thereof include alkynyl groups such as ethynyl group, propynyl group, butynyl group, pentynyl group, hexynyl group, heptynyl group, octynyl group, nonynyl group, decynyl group, undecynyl group and dodecynyl group.
- aromatic hydrocarbon group examples include a phenyl group and a naphthyl group.
- Examples of the alicyclic hydrocarbon group include a saturated or unsaturated cyclic hydrocarbon group, and examples of the cyclic hydrocarbon group include a cyclopropyl group, a cyclobutyl group, a cyclohexyl group, a cyclopentyl group, an adamantyl group, and a norbornyl group.
- the groups can be mentioned.
- R is preferably an alkyl group having 1 to 10 carbon atoms. Since R is an alkyl group having 1 to 10 carbon atoms, the fluoroisobutylene derivative of the general formula (4) and the fluoroisobutane derivative of the general formula (8), which are raw materials for the fluorine-containing pyrimidine compound, can be easily prepared. it can.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or-ConA 1 a 2, preferably a hydrogen atom, the number a halogen atom or a C 1 Represents ⁇ 10 hydrocarbon groups.
- X and Y may be the same or different, respectively.
- the halogen atom is F, Cl, Br or I, and preferably F or Cl.
- the hydrocarbon group having 1 to 10 carbon atoms is not particularly limited as long as it is a hydrocarbon group composed of a carbon atom and a hydrogen atom.
- the hydrocarbon having 1 to 10 carbon atoms in R is described above. Can be the basis.
- -C n F 2n + 1 is not particularly limited as long as it is a perfluoroalkyl group consisting of carbon atoms and fluorine atoms, be linear or may be branched. Further, n is an integer of 1 to 10, preferably an integer of 1 to 3.
- a 1 contained in -OA 1 and -SO m A 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
- a 1 and A 2 contained in -NA 1 A 2 independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 and A 2 may be the same or different, respectively.
- a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- a 1 contained in -COOA 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- a 1 and A 2 contained in -CONA 1 A 2 independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 and A 2 may be the same or different, respectively.
- a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- Z represents CW or N.
- W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (n is an integer of 1 to 10), a nitro group, a boronate group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or-ConA 1 a 2, preferably a hydrogen atom, the number a halogen atom or a C 1 Represents ⁇ 10 hydrocarbon groups.
- the halogen atom is F, Cl, Br or I, and preferably F or Cl.
- the hydrocarbon group having 1 to 10 carbon atoms is not particularly limited as long as it is a hydrocarbon group composed of a carbon atom and a hydrogen atom. can do.
- -C n F 2n + 1 is not particularly limited as long as it is a perfluoroalkyl group consisting of carbon atoms and fluorine atoms, be linear or may be branched. Further, n is an integer of 1 to 10, preferably an integer of 1 to 3.
- a 1 included in the -SO m represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- m is an integer of 0 to 3, preferably an integer of 0 to 2, and more preferably an integer of 0 to 1.
- a 1 and A 2 contained in -NA 1 A 2 independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 and A 2 may be the same or different, respectively.
- a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- a 1 contained in ⁇ COOA 1 represents a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 represents a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- a 1 and A 2 contained in -CONA 1 A 2 independently represent a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms.
- a 1 and A 2 may be the same or different, respectively.
- a 1 and A 2 represent a hydrocarbon group having 1 to 10 carbon atoms, for example, it can be a hydrocarbon group having 1 to 10 carbon atoms in the above R.
- W and X when W and X are adjacent to each other, W and X may be bonded to each other to form a ring together with the carbon atom to which they are bonded, and W and Y may be formed. When adjacent, W and Y may bond to each other to form a ring with the carbon atoms to which they bond.
- the ring thus formed may be an aromatic ring or a non-aromatic ring, and may be a carbon ring or a heterocycle.
- the number of carbon atoms on the ring is not particularly limited, but is preferably 4 to 20, more preferably 6 to 20, and even more preferably 6 to 10. Examples of such a ring include a benzothiophene ring and the like. Among these, the benzothiazole ring is preferable.
- the fluorine-containing pyrimidine compound in one embodiment has a specific substituent (thiophene group or thiazole group) at the 2-position of the pyrimidine ring, and a specific substituent (-OR,) above the 4-position, 5-position, and 6-position of the pyrimidine ring. Since it has -CF 3 , -F), it can have an excellent effect from the viewpoint of structural expandability.
- desired biological activity for example, growth inhibitory activity of various viruses, antibacterial activity of various bacteria, antitumor activity
- control activity of pathogens such as rice blast can be expected.
- the thiophene ring structure or thiazole ring structure located on the 2-position of the pyrimidine ring may or may not have a substituent.
- the thiophene ring structure or the thiazole ring structure having a substituent can impart additional properties to the fluorine-containing pyrimidine compound in one embodiment.
- the substituents on the 4- and 6-positions of the pyrimidine ring are different groups (-OR and -F), they can be easily derivatized into an asymmetrical structure and can be expected to be used as an intermediate. .. More specifically, a derivative can be obtained by modifying -OR by reacting a fluorine-containing pyrimidine compound under acidic conditions.
- fluorine-containing pyrimidine compound in one embodiment is useful in the field of electronic materials such as organic semiconductors and liquid crystals.
- the method for producing a fluorine-containing pyrimidine compound in one embodiment is (A) A fluorine-containing pyrimidine compound of the following general formula (1) by reacting a fluoroisobutylene derivative represented by the following general formula (4) with a compound represented by the following general formula (5) or a salt thereof. The process of getting (B) A fluorine-containing pyrimidine compound of the following general formula (2) by reacting a fluoroisobutylene derivative represented by the following general formula (4) with a compound represented by the following general formula (6) or a salt thereof.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- R is the same as that defined in the compounds of the general formulas (1) to (3) described above, and in the general formulas (5) to (7), X, Y and Z, respectively. Are the same as those defined in the compounds of the general formulas (1) to (3) described above.
- Z is CW, as described above, when W and X are adjacent to each other, W and X are bonded to each other together with the carbon atom to which they are bonded.
- a ring may be formed, and when W and Y are adjacent to each other, W and Y may be bonded to each other to form a ring together with a carbon atom to which they are bonded.
- R in the above general formulas (1) to (4) preferably represents an alkyl group having 1 to 10 carbon atoms.
- the R in the general formula (4) can be, for example, an alkyl group having 1 to 10 carbon atoms in the R in the general formulas (1) to (3) described above.
- reaction formula (A) The reaction of the above (a) between the fluoroisobutylene derivative represented by the general formula (4) and the compound represented by the general formula (5) is represented by the following reaction formula (A).
- reaction formula (B) The reaction of the above (b) between the fluoroisobutylene derivative represented by the general formula (4) and the compound represented by the general formula (6) is represented by the following reaction formula (B).
- reaction formula (C) The reaction of the above (c) between the fluoroisobutylene derivative represented by the general formula (4) and the compound represented by the general formula (7) is represented by the following reaction formula (C).
- the compounds of the general formulas (5) to (7) may be in the form of salts, respectively.
- the counterion is not particularly limited as long as it is a monovalent anion, and examples thereof include halide ions such as F ⁇ , Cl ⁇ , Br ⁇ , and I ⁇ .
- the above reactions (a) to (c) can be carried out in one step in the presence of a hydrogen halide scavenger. Therefore, the fluorine-containing pyrimidine compounds of the above general formulas (1) to (3) can be easily obtained.
- a cyclic pyrimidine structure is formed between the fluoroisobutylene derivative represented by the general formula (4) and the amidino group of the compounds of the general formulas (5) to (7). Is formed.
- a group derived from the thiophene ring structure or thiazole ring structure of the compounds of the general formulas (5) to (7) is located at the 2-position of the pyrimidine structure. Further, -OR, CF 3 , and F derived from the fluoroisobutylene derivative are located at the 4-position, 5-position, and 6-position of the pyrimidine structure, respectively.
- the hydrogen halide trapping agent is a hydrogen atom derived from an amidino group in the compounds of the general formulas (5) to (7) in the reaction formulas (A) to (C) above, and a fluoroisobutylene derivative of the general formula (4). It is a substance having a function of capturing hydrogen fluoride (HF) formed from fluorine atoms derived from.
- hydrogen halide trapping agents include inorganic compounds such as sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium fluoride and potassium fluoride, pyridine, triethylamine, diisopropylethylamine, diazabicyclononen and diaza. Organic nitrogen derivatives such as zabicycloundecene, methyltriazabicyclodecene and diazabicyclooctane can be used.
- the reaction temperature during the reaction of (a) to (c) is preferably 0 to 100 ° C, more preferably 5 to 50 ° C, and even more preferably 10 to 20 ° C.
- the reaction time during the reaction of (a) to (c) is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and even more preferably 2 to 12 hours.
- the solvents used in the reactions (a) to (c) above include tetrahydrofuran, monoglime, jigglime, triglime, tetraglime, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and the like.
- examples thereof include an aprotic polar solvent such as sulfoxide, or a biphasic solvent in which a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether are used.
- quaternary ammonium halides such as benzyltriethylammonium chloride, quaternary phosphonium halides, crown ethers and the like can be used.
- the method for producing a fluorine-containing pyrimidine compound in another embodiment is (D) A fluorine-containing pyrimidine compound of the following general formula (1) by reacting a fluoroisobutane derivative represented by the following general formula (8) with a compound represented by the following general formula (5) or a salt thereof.
- the process of getting (E) A fluorine-containing pyrimidine compound of the following general formula (2) by reacting a fluoroisobutane derivative represented by the following general formula (8) with a compound represented by the following general formula (6) or a salt thereof.
- a fluorine-containing pyrimidine compound of the following general formula (3) by reacting a fluoroisobutane derivative represented by the following general formula (8) with a compound represented by the following general formula (7) or a salt thereof.
- Q represents a halogen atom, -OA 1 , -SO m A 1 (m is an integer of 0 to 3) or -NA 1 A 2 .
- R represents a hydrocarbon group having 1 to 12 carbon atoms.
- X and Y are each independently a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, Z represents CW or N W is a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 10 carbon atoms, -C n F 2n + 1 (where n is an integer of 1-10), a nitro group, a boronic acid group, -OA 1, -SO m a 1 (m is an integer of 0 ⁇ 3), - NA 1 a 2, represents -COOA 1 or -CONA 1 a 2, A 1 and A 2 independently represent a hydrogen atom or a hydrocarbon group having 1
- R is the same as that defined in the compounds of the general formulas (1) to (3) described above, and is a halogen atom, -OA 1 , -SO m A 1 (m is 0 to 3). ) And -NA 1 A 2 are the same as those defined in the compounds of the general formulas (1) to (3) described above.
- R in the above general formulas (1) to (3) and (8) preferably represents an alkyl group having 1 to 10 carbon atoms.
- the R in the general formula (8) can be, for example, an alkyl group having 1 to 10 carbon atoms in the R in the general formulas (1) to (3) described above.
- reaction formula (D) The reaction of the above (d) between the fluoroisobutane derivative represented by the general formula (8) and the compound represented by the general formula (5) is represented by the following reaction formula (D).
- reaction formula (E) The reaction of the above (e) between the fluoroisobutane derivative represented by the general formula (8) and the compound represented by the general formula (6) is represented by the following reaction formula (E).
- reaction formula (F) The reaction of the above (f) between the fluoroisobutane derivative represented by the general formula (8) and the compound represented by the general formula (7) is represented by the following reaction formula (F).
- the compounds of the general formulas (5) to (7) may be in the form of salts, respectively.
- the counterion is not particularly limited as long as it is a monovalent anion, and examples thereof include halide ions such as F ⁇ , Cl ⁇ , Br ⁇ , and I ⁇ .
- the above reactions (D) to (F) can be carried out in one step. Therefore, the fluorine-containing pyrimidine compounds of the above general formulas (1) to (3) can be easily obtained.
- a cyclic pyrimidine structure is formed between the fluoroisobutane derivative represented by the general formula (8) and the amidino group of the compounds of the general formulas (5) to (7). Is formed.
- a group derived from the thiophene ring structure or thiazole ring structure of the compounds of the general formulas (5) to (7) is located at the 2-position of the pyrimidine structure.
- -OR, CF 3 , and F derived from the fluoroisobutane derivative are located at the 4-position, 5-position, and 6-position of the pyrimidine structure, respectively.
- the reaction temperature during the reaction of (d) to (f) is preferably 0 to 100 ° C, more preferably 5 to 50 ° C, and even more preferably 10 to 20 ° C.
- the reaction time during the reaction of (d) to (f) is preferably 0.5 to 48 hours, more preferably 1 to 36 hours, and even more preferably 4 to 24 hours.
- the same hydrogen halide scavengers as in the above (a) to (c) may be used.
- the solvents used in the reactions (d) to (f) above include tetrahydrofuran, monoglime, jigglime, triglime, tetraglime, acetonitrile, dimethylformamide, dimethylacetamide, methylpyrrolidone, dimethylethyleneurea, tetramethylurea, dimethylsulfoxide and the like.
- examples thereof include an aprotic polar solvent such as sulfoxide, or a biphasic solvent in which a protonic polar solvent such as water and a water-insoluble solvent such as dichloromethane, toluene and diethyl ether are used.
- quaternary ammonium halides such as benzyltriethylammonium chloride, quaternary phosphonium halides, crown ethers and the like can be used.
- room temperature is within the range of 20 ° C. ⁇ 5 ° C.
- Example 1 Production of 6-fluoro-4-methoxy-2- (2-thienyl) -5- (trifluoromethyl) pyrimidine Under ice-water cooling, 25 g of dichloromethane, 25 g of water and 10 g (61 mmol) of 2-amidinothiophene hydrochloride, 1,3 , 3,3-Tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propen 13 g (61 mmol) was added. Subsequently, 50 ml (0.24 mol) of a 5N sodium hydroxide aqueous solution was added dropwise so that the internal temperature did not exceed 10 ° C., and the temperature was raised to room temperature.
- Example 2 Production of 6-fluoro-4-methoxy-2- (3-thienyl) -5- (trifluoromethyl) pyrimidine Under ice-water cooling, 25 g of dichloromethane, 25 g of water and 10 g (61 mmol) of 3-amidinothiophene hydrochloride, 1,3 , 3,3-Tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propen 13 g (61 mmol) was added. Subsequently, 50 ml (0.24 mol) of a 5N sodium hydroxide aqueous solution was added dropwise so that the internal temperature did not exceed 10 ° C., and the temperature was raised to room temperature.
- Example 3 Production of 6-Fluoro-4-methoxy-2- (2-thiazolyl) -5- (trifluoromethyl) pyrimidine Under ice-water cooling, 50 g of dichloromethane, 50 g of water and 5 g (31 mmol) of 2-amidinothiazole hydrochloride, 1,3 , 3,3-Tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propen 4 g (18 mmol) was added. Subsequently, 15 ml (72 mmol) of a 5N sodium hydroxide aqueous solution was added dropwise so that the internal temperature did not exceed 10 ° C., and the temperature was raised to room temperature.
- Example 4 Instead of 1,3,3,3-tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propene of Example 1, 1,1,1,3,3-pentafluoro-3-methoxy Production of 6-fluoro-4-methoxy-2- (2-thienyl) -5- (trifluoromethyl) pyrimidine using -2- (trifluoromethyl) -propane Under ice-water cooling, 25 g of dichloromethane and 25 g of water.
- Example 5 Instead of 1,3,3,3-tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propene of Example 2, 1,1,1,3,3-pentafluoro-3-methoxy Production of 6-fluoro-4-methoxy-2- (3-thienyl) -5- (trifluoromethyl) pyrimidine using -2- (trifluoromethyl) -propane Under ice-water cooling, 25 g of dichloromethane and 25 g of water.
- Example 6 Instead of 1,3,3,3-tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propen of Example 3, 1,1,1,3,3-pentafluoro-3-methoxy Production of 6-fluoro-4-methoxy-2- (2-thiazolyl) -5- (trifluoromethyl) pyrimidine using -2- (trifluoromethyl) -propane under ice-water cooling, 50 g of dichloromethane and 50 g of water.
- Examples 4 to 6 the yield of the obtained compound was not calculated, but the system was based on 1,1,1,3,3-pentafluoro-3-methoxy-2-trifluoromethyl-propane. Types and amounts of impurities due to by-products that can be generated in the process of producing 1,3,3,3-tetrafluoro-1-methoxy-2- (trifluoromethyl) -1-propene. Is expected to increase. Therefore, it is considered that the production methods of Examples 1, 2 and 3 have higher yields of the obtained products as compared with the corresponding production methods of Examples 4, 5 and 6.
- Example 3 Evaluation test for rice blast Disease 6-fluoro-4-methoxy-2- (2-thiazolyl) -5- (trifluoromethyl) pyrimidine prepared in Example 3 was dissolved in acetone, and the solution was prepared to a concentration of 100,000 ppm. Prepared. Next, sterilized water was added to 1 ml of this acetone solution to make 50 ml, and a test solution having a concentration of 2000 ppm was prepared. Further, sterilized water was added to 10 ml of a separately prepared test solution having a concentration of 2000 ppm to make 20 ml, and a test solution having a concentration of 1000 ppm was prepared.
- no treatment means that 1 ml of acetone was diluted with sterilized water to 50 ml as a test solution, and the mixture was added dropwise to the medium. Further, “treated” means that the test solution obtained by diluting and adjusting to the set concentration was added dropwise to the medium.
- the fluorine-containing pyrimidine compound in the present invention exhibits a control activity against pathogens of rice blast and is effective as a compound exhibiting biological activity.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
[1] 下記一般式(1)、(2)または(3)で表される、含フッ素ピリミジン化合物。
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
[2] 前記Rは、炭素数1~10のアルキル基である、[1]に記載の含フッ素ピリミジン化合物。
[3] (a)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(c)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する、含フッ素ピリミジン化合物の製造方法。
[4] (d)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(f)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Qは、ハロゲン原子、-OA1、-SOmA1(mは0~3の整数である)または-NA1A2を表し、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する、含フッ素ピリミジン化合物の製造方法。
[5] 前記Rは、炭素数1~10のアルキル基である、[3]または[4]に記載の含フッ素ピリミジン化合物の製造方法。
一実施形態における含フッ素ピリミジン化合物は下記一般式(1)、(2)または(3)で表される。
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
エテニル基、プロペニル基、ブテニル基、ペンテニル基、ヘキセニル基、ヘプテニル基、オクテニル基、ノネニル基、デセニル基、ウンデセニル基、ドデセニル基等のアルケニル基;
エチニル基、プロピニル基、ブチニル基、ペンチニル基、ヘキシニル基、ヘプチニル基、オクチニル基、ノニニル基、デシニル基、ウンデシニル基、ドデシニル基等のアルキニル基等を挙げることができる。
一実施形態における含フッ素ピリミジン化合物の製造方法は、
(a)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(c)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する。
(d)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(f)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Qは、ハロゲン原子、-OA1、-SOmA1(mは0~3の整数である)または-NA1A2を表し、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する。
6-フルオロ-4-メトキシ-2-(2-チエニル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン25g、水25gに2-アミジノチオフェン塩酸塩10g(61mmol)、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン13g(61mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液50ml(0.24mol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行い、下記の式(9)で示される化合物(化学式:C10H6F4N2OS、分子量:278.22g/mol)4.6gを得た。得られた化合物の単離収率は14%であった。
マススペクトル(APCI、m/z):278([M]+)
1H-NMR(300MHz、CDCl3) δppm:8.05(d,1H)、7.59(d,1H)、7.15(dd,1H)、4.18(s,3H)
19F-NMR(300MHz、C6F6) δppm:-58.26(d,3F)、-61.72(dd,1F)
6-フルオロ-4-メトキシ-2-(3-チエニル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン25g、水25gに3-アミジノチオフェン塩酸塩10g(61mmol)、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン13g(61mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液50ml(0.24mol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行い、下記の式(10)で示される化合物(化学式:C10H6F4N2OS、分子量:278.22g/mol)2.0gを得た。得られた化合物の単離収率は58%であった。
マススペクトル(APCI、m/z):278([M]+)
1H-NMR(300MHz、CDCl3) δppm:8.40(d,1H)、7.84(d,1H)、7.39(dd,1H)、4.20(s,3H)
19F-NMR(300MHz、C6F6) δppm:-58.40(d,3F)、-61.79(dd,1F)
6-フルオロ-4-メトキシ-2-(2-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン50g、水50gに2-アミジノチアゾール塩酸塩5g(31mmol)、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン4g(18mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液15ml(72mmol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行い、下記の式(11)で示される化合物(化学式:C9H5F4N3OS、分子量:279.21g/mol)0.6gを得た。得られた化合物の単離収率は7%であった。
マススペクトル(APCI、m/z):279([M]+)
1H-NMR(300MHz、CDCl3) δppm:8.12(d,1H)、7.67(d,1H)、4.28(s,3H)
19F-NMR(300MHz、C6F6) δppm:-58.75(d,3F)、-59.83(dd,1F)
実施例1の1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペンの代わりに、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパンを使用した、6-フルオロ-4-メトキシ-2-(2-チエニル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン25g、水25gに2-アミジノチオフェン塩酸塩10g(61mmol)、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパン14g(61mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液65ml(0.31mol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行った。得られた化合物の分析結果は、実施例1の生成物と同様であった。
実施例2の1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペンの代わりに、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパンを使用した、6-フルオロ-4-メトキシ-2-(3-チエニル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン25g、水25gに3-アミジノチオフェン塩酸塩10g(61mmol)、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパン14g(61mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液65ml(0.31mol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行った。得られた化合物の分析結果は、実施例2の生成物と同様であった。
実施例3の1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペンの代わりに、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパンを使用した、6-フルオロ-4-メトキシ-2-(2-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
氷水冷下、ジクロロメタン50g、水50gに2-アミジノチアゾール塩酸塩5g(31mmol)、1,1,1,3,3-ペンタフルオロ-3-メトキシ-2-(トリフルオロメチル)-プロパン4g(18mmol)を加えた。続いて、内温が10℃を越えないように5N 水酸化ナトリウム水溶液19ml(90mmol)を滴下し、室温まで昇温した。約16時間後、有機相を分取し、次いでジクロロメタンを減圧留去した後、酢酸エチルに溶解させてカラム精製を行った。得られた化合物の分析結果は、実施例3の生成物と同様であった。
6-フルオロ-4-メトキシ-2-(5-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
5-アミジノチアゾール塩酸塩0.7g(4.3mmol)をアセトニトリル45mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン1.1g(5.2mmol)とN,N-ジイソプロピルエチルアミン2.9g(22.4mmol)を加え、室温で22.5時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(12)で示される化合物0.5g(1.7mmol)を得た。得られた化合物の単離収率は39.2%であった。
マススペクトル(APCI、m/z):279.7([M+H]+)
1H-NMR(400MHz、CDCl3) δppm:8.98(s,1H)、8.78(s,1H)、4.21(s,3H)
6-フルオロ-4-メトキシ-2-(4-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
4-アミジノチアゾール塩酸塩0.5g(3.1mmol)をアセトニトリル30mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.8g(3.8mmol)とN,N-ジイソプロピルエチルアミン2.1g(16.2mmol)を加え、室温で17時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(13)で示される化合物0.5g(1.8mmol)を得た。得られた化合物の単離収率は58.5%であった。
マススペクトル(APCI、m/z):279.4([M+H]+)
1H NMR(400MHz、CDCl3) δppm:8.97(d,J=2.1Hz,1H)、8.51(d,J=2.1Hz,1H)、4.26(s,3H)
6-フルオロ-2-(5-フルオロ-2-チエニル)-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
5-フルオロ-2-アミジノチオフェン塩酸塩0.6g(3.4mmol)をアセトニトリル35mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.8g(3.8mmol)とN,N-ジイソプロピルエチルアミン2.3g(17.8mmol)を加え、室温で22時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(14)で示される化合物0.6g(2.1mmol)を得た。得られた化合物の単離収率は61.2%であった。
マススペクトル(APCI、m/z):295.6([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.77(dd,J=4.4,3.8Hz,1H)、6.59(dd,J=4.3,1.5Hz,1H)、4.16(s,3H)
2-(5-クロロ-2-チエニル)-6-フルオロ-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
5-クロロチオフェン-2-カルボキシイミドアミド塩酸塩0.5g(2.6mmol)をアセトニトリル25mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.7g(3.3mmol)とN,N-ジイソプロピルエチルアミン1.7g(13.2mmol)を加え、室温で28時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(15)で示される化合物0.3g(1.1mmol)を得た。得られた化合物の単離収率は41.9%であった。
マススペクトル(APCI、m/z):312.0([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.86(d,J=4.0Hz,1H)、7.00(d,J=4.0Hz,1H)、4.17(s,3H)
2-(4-ブロモ-3-チエニル)-6-フルオロ-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
4-ブロモ-3-アミジノチオフェン塩酸塩の粗精製物0.4gをアセトニトリル15mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.4g(1.9mmol)とN,N-ジイソプロピルエチルアミン1.0g(7.7mmol)を加え、室温で19.8時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(16)で示される化合物0.1g(0.2mmol)を得た。得られた化合物の3ステップ収率は4.2%であった。
マススペクトル(APCI、m/z):357.7([M+H]+)
1H NMR(400MHz、CDCl3) δppm:8.38(d,J=3.7Hz,1H)、7.42(d,J=3.7Hz,1H)、4.25(s,3H)
6-フルオロ-2-(5-ヨード-2-チエニル)-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
5-ヨード-2-アミジノチオフェン塩酸塩0.6g(2.1mmol)をアセトニトリル21mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.5g(2.4mmol)とN,N-ジイソプロピルエチルアミン1.4g(10.8mmol)を加え、室温で19時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(17)で示される化合物0.5g(1.2mmol)を得た。得られた化合物の単離収率は58.2%であった。
マススペクトル(APCI、m/z):403.6([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.69(d,J=4.0Hz,1H)、7.33(d,J=4.0Hz,1H)、4.17(s,3H)
6-フルオロ-4-メトキシ-5-(トリフルオロメチル)-2-[4-(トリフルオロメチル)-2-チアゾリル]ピリミジンの製造
4-(トリフルオロメチル)-1,3-チアゾール-2-カルボキシイミドアミド塩酸塩0.5g(2.1mmol)をアセトニトリル22mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.6g(2.8mmol)とN,N-ジイソプロピルエチルアミン1.5g(11.6mmol)を加え、室温で20.2時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(18)で示される化合物0.2g(0.6mmol)を得た。得られた化合物の単離収率は27.1%であった。
マススペクトル(APCI、m/z):347.0([M-H]-)
1H NMR(400MHz、CDCl3) δppm:8.04(s,1H)、4.29(s,1H)
6-フルオロ-4-メトキシ-2-(4-メチル-2-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
4-メチル-2-アミジノ-1,3-チアゾール塩酸塩0.2g(1.7mmol)をアセトニトリル42mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.5g(2.3mmol)とN,N-ジイソプロピルエチルアミン1.4g(10.8mmol)を加え、室温で23.2時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(19)で示される化合物0.6g(2.0mmol)を得た。得られた化合物の単離収率は49.1%であった。
マススペクトル(APCI、m/z):293.1([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.23(d,J=0.9Hz,1H)、4.25(s,3H)、2.61(d,J=0.9Hz,3H)
6-フルオロ-4-メトキシ-2-(2-メチル-4-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
2-メチル-4-アミジノチアゾール塩酸塩0.2g(1.7mmol)をアセトニトリル17mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.5g(2.4mmol)とN,N-ジイソプロピルエチルアミン1.2g(9.3mmol)を加え、室温で22.3時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(20)で示される化合物0.2g(0.8mmol)を得た。得られた化合物の単離収率は、46.6%であった。
マススペクトル(APCI、m/z):293.2([M+H]+)
1H NMR(400MHz、CDCl3) δppm:8.31(s,1H),4.23(s,3H),2.84(s,3H)
6-フルオロ-4-メトキシ-2-(5-ニトロ-2-チエニル)-5-(トリフルオロメチル)ピリミジンの製造
5-ニトロ-2-アミジノチオフェン塩酸塩の粗精製物0.7gをアセトニトリル33mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.8g(3.8mmol)とN,N-ジイソプロピルエチルアミン2.2g(17.0mmol)を加え、室温で21時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(21)で示される化合物0.2g(0.6mmol)を得た。得られた化合物の3ステップ収率は、19%であった。
マススペクトル(APCI、m/z):322.3([M-H]-)
1H NMR(400MHz、CDCl3) δppm:7.97(d,J=4.3Hz,1H)、7.94(d,J=4.3Hz,1H)、4.23(s,3H)
6-フルオロ-4-メトキシ-2-[5-(メチルスルファニル)-2-チエニル]-5-(トリフルオロメチル)ピリミジンの製造
5-(メチルスルファニル)チオフェン-2-カルボキシイミドアミド塩酸塩0.5g(2.4mmol)をアセトニトリル24mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.6g(2.8mmol)とN,N-ジイソプロピルエチルアミン1.6g(12.4mmol)を加え、室温で18.3時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(22)で示される化合物0.5g(1.6mmol)を得た。得られた化合物の単離収率は67.6%であった。
マススペクトル(APCI、m/z):324.0([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.91(d,J=4.0Hz,1H)、6.99(d,J=4.0Hz,1H)、4.17(s,3H)、2.62(s,3H).
6-フルオロ-2-[5-(メタンスルフォニル)-2-チエニル]-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
5-メタンスルフォニル-2-アミジノチオフェン塩酸塩0.5g(2.1mmol)をアセトニトリル21mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.5g(2.3mmol)とN,N-ジイソプロピルエチルアミン1.4g(10.8mmol)を加え、室温で13.5時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(23)で示される化合物0.3g(0.9mmol)を得た。得られた化合物の単離収率は45.3%であった。
マススペクトル(APCI、m/z):355.5([M-H]-)
1H NMR(400MHz、CDCl3) δppm:8.03(d,J=4.0Hz,1H)、7.74(d,J=4.0Hz,1H)、4.21(s,3H)、3.24(s,3H)
2-[2-(ジメチルアミノ)-5-チアゾリル]-6-フルオロ-4-メトキシ-5-(トリフルオロメチル)ピリミジンの製造
2-(ジメチルアミノ)-5-アミジノ-1,3-チアゾール塩酸塩0.1g(0.7mmol)をアセトニトリル7mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.2g(0.9mmol)とN,N-ジイソプロピルエチルアミン0.5g(3.9mmol)を加え、室温で18.3時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(24)で示される化合物0.1g(0.2mmol)を得た。得られた化合物の単離収率は27.0%であった。
マススペクトル(APCI、m/z):323.1([M+H]+)
1H NMR(400MHz、CDCl3) δppm:8.19(s,1H)、4.12(s,3H)、3.22(s,6H)
6-フルオロ-4-メトキシ-2-(2-メトキシ-5-チアゾリル)-5-(トリフルオロメチル)ピリミジンの製造
2-メトキシ-5-アミジノ-1,3-チアゾール塩酸塩0.6g(3.3mmol)をアセトニトリル33mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.8g(3.7mmol)とN,N-ジイソプロピルエチルアミン2.2g(17.0mmol)を加え、室温で19.5時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(25)で示される化合物0.2g(0.8mmol)を得た。得られた化合物の単離収率は23.7%であった。
マススペクトル(APCI、m/z):310.2([M+H]+)
1H NMR(400MHz、CDCl3) δppm:7.76(s,1H)、4.13(s,3H)、3.46(s,3H)
6-フルオロ-4-メトキシ-2-[5-(メトキシカルボニル)-2-チエニル]-5-(トリフルオロメチル)ピリミジンの製造
5-アミジノチオフェン-2-カルボン酸メチル塩酸塩0.6g(2.8mmol)をアセトニトリル28mlに溶解し、1,3,3,3-テトラフルオロ-1-メトキシ-2-(トリフルオロメチル)-1-プロペン0.7g(3.3mmol)とN,N-ジイソプロピルエチルアミン1.9g(14.7mmol)を加え、室温で20.8時間撹拌した。撹拌後、反応液をカラム精製し、下記の式(26)で示される化合物0.6g(1.6mmol)を得た。得られた化合物の単離収率は60.0%であった。
マススペクトル(APCI、m/z):335.3([M-H]-)
1H NMR(400MHz、CDCl3) δppm:8.01(d,J=4.0Hz,1H)、7.80(d,J=4.0Hz,1H)、4.21(s,3H)、3.94(s,3H)
イネいもち病に対する評価試験
実施例3で作製した6-フルオロ-4-メトキシ-2-(2-チアゾリル)-5-(トリフルオロメチル)ピリミジンをアセトンに溶かし、100000ppmの濃度になるように溶液を調製した。次いで、このアセトン溶液1mlに滅菌水を加え50mlとし、濃度2000ppmの被験液を調製した。また、別途用意した濃度2000ppmの被験液10mlに滅菌水を加え20mlとし、濃度1000ppmの被験液を調製した。濃度2000ppmの被験液および濃度1000ppmの被験液を、別途作製したオートミール培地に1000μlそれぞれ滴下し、風乾させた。続いて、4mmのイネいもち病ディスクを、菌叢がオートミール培地の処理面に接するように設置した。その後、オートミール培地を25℃の恒温室に6日間静置した後、菌糸の伸長長さを調査した。その結果を表1に示す。なお、防除価は、下記式にしたがって算出した。下記式において「無処理」とは、被験液としてアセトン1mlを滅菌水で50mlに希釈したものを作製し、培地に滴下処理したことを表す。また、「処理済」とは、設定濃度に希釈調整処理を行った被験液を培地に滴下処理したことを表す。
Claims (5)
- 下記一般式(1)、(2)または(3)で表される、含フッ素ピリミジン化合物。
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。) - 前記Rは、炭素数1~10のアルキル基である、請求項1に記載の含フッ素ピリミジン化合物。
- (a)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(c)下記一般式(4)で表されるフルオロイソブチレン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する、含フッ素ピリミジン化合物の製造方法。 - (d)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(5)で表される化合物またはその塩とを反応させることにより、下記一般式(1)の含フッ素ピリミジン化合物を得る工程、
(f)下記一般式(8)で表されるフルオロイソブタン誘導体と、下記一般式(7)で表される化合物またはその塩とを反応させることにより、下記一般式(3)の含フッ素ピリミジン化合物を得る工程、
Qは、ハロゲン原子、-OA1、-SOmA1(mは0~3の整数である)または-NA1A2を表し、
Rは、炭素数1~12の炭化水素基を表し、
XおよびYは、それぞれ独立して、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
Zは、CWまたはNを表し、
Wは、水素原子、ハロゲン原子、炭素数1~10の炭化水素基、-CnF2n+1(nは1~10の整数である)、ニトロ基、ボロン酸基、-OA1、-SOmA1(mは0~3の整数である)、-NA1A2、-COOA1または-CONA1A2を表し、
A1およびA2は、それぞれ独立して、水素原子または炭素数1~10の炭化水素基を表す。)
を有する、含フッ素ピリミジン化合物の製造方法。 - 前記Rは、炭素数1~10のアルキル基である、請求項3または4に記載の含フッ素ピリミジン化合物の製造方法。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20880783.4A EP4053123A4 (en) | 2019-11-01 | 2020-10-29 | FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME |
JP2021553690A JP7085697B2 (ja) | 2019-11-01 | 2020-10-29 | 含フッ素ピリミジン化合物およびその製造方法 |
CN202080070690.1A CN114502551B (zh) | 2019-11-01 | 2020-10-29 | 含氟嘧啶化合物及其制备方法 |
US17/768,556 US20240124436A1 (en) | 2019-11-01 | 2020-10-29 | Fluorine-containing pyrimidine compound and method for producing same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019-200237 | 2019-11-01 | ||
JP2019200237 | 2019-11-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021085550A1 true WO2021085550A1 (ja) | 2021-05-06 |
Family
ID=75716366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2020/040682 WO2021085550A1 (ja) | 2019-11-01 | 2020-10-29 | 含フッ素ピリミジン化合物およびその製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240124436A1 (ja) |
EP (1) | EP4053123A4 (ja) |
JP (1) | JP7085697B2 (ja) |
CN (1) | CN114502551B (ja) |
WO (1) | WO2021085550A1 (ja) |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59104364A (ja) * | 1982-12-03 | 1984-06-16 | Nippon Mektron Ltd | 新規ピリミジン誘導体およびその製造法 |
JPS63216877A (ja) * | 1987-03-06 | 1988-09-09 | Nippon Kayaku Co Ltd | 含フツ素ピリミジン誘導体 |
US5922726A (en) * | 1996-07-15 | 1999-07-13 | American Cyanamid Company | Herbicidal 6-thienyl pyridines and 4-thienyl pyrimidines |
EP1334956A2 (en) | 2002-02-07 | 2003-08-13 | Sumitomo Chemical Company, Limited | Method for preparing sulfone or sulfoxide compound |
EP1364946A1 (en) | 2001-02-08 | 2003-11-26 | Kumiai Chemical Industry Co., Ltd. | Isoxazoline derivative and herbicide comprising the same as active ingredient |
WO2009129905A1 (de) | 2008-04-21 | 2009-10-29 | Merck Patent Gmbh | Pyridazinonderivate |
WO2011019405A1 (en) | 2009-08-14 | 2011-02-17 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
CA2781404A1 (en) | 2009-11-26 | 2011-06-03 | Basf Se | Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts |
WO2012027236A1 (en) | 2010-08-23 | 2012-03-01 | Schering Corporation | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012098049A1 (en) | 2011-01-18 | 2012-07-26 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of statins in the presence of base |
US20130090476A1 (en) | 2009-06-23 | 2013-04-11 | Bayer Cropscience Ag | Thiazolylpiperidine Derivatives as Fungicides |
WO2013086131A1 (en) | 2011-12-06 | 2013-06-13 | The Trustees Of The University Of Pennsylvania | Inhibitors targeting drug-resistant influenza a |
WO2016196644A1 (en) | 2015-06-01 | 2016-12-08 | Bantam Pharmaceutical, Llc | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto |
WO2017139603A1 (en) | 2016-02-12 | 2017-08-17 | Astrazeneca Ab | Halo-substituted piperidines as orexin receptor modulators |
WO2020116926A1 (en) * | 2018-12-07 | 2020-06-11 | Samsung Electronics Co., Ltd. | Electronic device for detecting location of user and method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2707295A1 (fr) * | 1993-06-07 | 1995-01-13 | Rhone Poulenc Agrochimie | Fongicides pyrazoles substitués en position 3 par un hétérocycle. |
US5747423A (en) * | 1996-07-15 | 1998-05-05 | American Cyanamid Company | Herbicidal 6-thienyl and 4-thienyl pyrimidines |
JP2000001460A (ja) * | 1998-06-11 | 2000-01-07 | Sumitomo Chem Co Ltd | アクリル酸誘導体及びその用途 |
JP2008505957A (ja) * | 2004-07-14 | 2008-02-28 | ビーエーエスエフ アクチェンゲゼルシャフト | 2−置換ピリミジン、その調製方法および有害菌類を防除するためのその使用 |
GB0808664D0 (en) * | 2008-05-13 | 2008-06-18 | Syngenta Ltd | Chemical compounds |
CN109503562B (zh) * | 2018-12-26 | 2022-01-14 | 西华大学 | 2-[4-(2-噻吩基)]嘧啶基脲衍生物及其制备方法和应用 |
CN109942561B (zh) * | 2018-12-26 | 2022-01-14 | 西华大学 | 4-(2-噻吩基)嘧啶衍生物及其制备方法和应用 |
-
2020
- 2020-10-29 JP JP2021553690A patent/JP7085697B2/ja active Active
- 2020-10-29 US US17/768,556 patent/US20240124436A1/en active Pending
- 2020-10-29 CN CN202080070690.1A patent/CN114502551B/zh active Active
- 2020-10-29 WO PCT/JP2020/040682 patent/WO2021085550A1/ja active Application Filing
- 2020-10-29 EP EP20880783.4A patent/EP4053123A4/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59104364A (ja) * | 1982-12-03 | 1984-06-16 | Nippon Mektron Ltd | 新規ピリミジン誘導体およびその製造法 |
JPS63216877A (ja) * | 1987-03-06 | 1988-09-09 | Nippon Kayaku Co Ltd | 含フツ素ピリミジン誘導体 |
US5922726A (en) * | 1996-07-15 | 1999-07-13 | American Cyanamid Company | Herbicidal 6-thienyl pyridines and 4-thienyl pyrimidines |
EP1364946A1 (en) | 2001-02-08 | 2003-11-26 | Kumiai Chemical Industry Co., Ltd. | Isoxazoline derivative and herbicide comprising the same as active ingredient |
EP1334956A2 (en) | 2002-02-07 | 2003-08-13 | Sumitomo Chemical Company, Limited | Method for preparing sulfone or sulfoxide compound |
WO2009129905A1 (de) | 2008-04-21 | 2009-10-29 | Merck Patent Gmbh | Pyridazinonderivate |
US20130090476A1 (en) | 2009-06-23 | 2013-04-11 | Bayer Cropscience Ag | Thiazolylpiperidine Derivatives as Fungicides |
WO2011019405A1 (en) | 2009-08-14 | 2011-02-17 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
CA2781404A1 (en) | 2009-11-26 | 2011-06-03 | Basf Se | Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts |
WO2012027236A1 (en) | 2010-08-23 | 2012-03-01 | Schering Corporation | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012098049A1 (en) | 2011-01-18 | 2012-07-26 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of statins in the presence of base |
WO2013086131A1 (en) | 2011-12-06 | 2013-06-13 | The Trustees Of The University Of Pennsylvania | Inhibitors targeting drug-resistant influenza a |
WO2016196644A1 (en) | 2015-06-01 | 2016-12-08 | Bantam Pharmaceutical, Llc | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto |
WO2017139603A1 (en) | 2016-02-12 | 2017-08-17 | Astrazeneca Ab | Halo-substituted piperidines as orexin receptor modulators |
WO2020116926A1 (en) * | 2018-12-07 | 2020-06-11 | Samsung Electronics Co., Ltd. | Electronic device for detecting location of user and method thereof |
Non-Patent Citations (7)
Title |
---|
ACS CATALYSIS, vol. 8, 2018, pages 2839 - 2843 |
ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 57, 2018, pages 6926 - 6929 |
DAS SIVA PRASAD; BORUAH JEENA JYOTI; CHETRY HIRAN; ISLAM NASHREEN S.: "Selective oxidation of organic sulfides by mononuclear and dinuclear peroxotungsten(VI) complexes", TETRAHEDRON LETTERS, vol. 53, no. 9, 1 January 1900 (1900-01-01), Amsterdam , NL , pages 1163 - 1168, XP028887804, ISSN: 0040-4039, DOI: 10.1016/j.tetlet.2011.12.105 |
JEYAKUMAR, K. ; CHAKRAVARTHY, R.D. ; CHAND, D.K.: "Simple and efficient method for the oxidation of sulfides to sulfones using hydrogen peroxide and a Mo(VI) based catalyst", CATALYSIS COMMUNICATIONS, vol. 10, no. 14, 25 August 2009 (2009-08-25), AMSTERDAM, NL , pages 1948 - 1951, XP026470090, ISSN: 1566-7367, DOI: 10.1016/j.catcom.2009.07.009 |
See also references of EP4053123A4 |
TETRAHEDRON, vol. 72, 2016, pages 3250 - 3255 |
YOSHIO INOUYE, YOICHI HIGUCHI: "A facile one-pot preparation of 2-methyl-and 2-phenyl-4- fluoro-5-trifluoromethyl-6-methoxypyrimidine from methyl 2-hydryl-2-(-methyl)--propyl ether", JOURNAL OF FLUORINE CHEMISTRY, ELSEVIER, NL, vol. 27, no. 2, 1 February 1985 (1985-02-01), NL , pages 231 - 236, XP055717031, ISSN: 0022-1139, DOI: 10.1016/S0022-1139(00)84991-X * |
Also Published As
Publication number | Publication date |
---|---|
EP4053123A1 (en) | 2022-09-07 |
JPWO2021085550A1 (ja) | 2021-05-06 |
EP4053123A4 (en) | 2023-10-11 |
CN114502551B (zh) | 2023-08-22 |
US20240124436A1 (en) | 2024-04-18 |
JP7085697B2 (ja) | 2022-06-16 |
CN114502551A (zh) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6802416B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
JP2020517677A5 (ja) | ||
CA2653319A1 (en) | Hsp90 inhibitor | |
WO2021095577A1 (ja) | 含フッ素ピラゾール化合物およびその製造方法 | |
JP2013530130A (ja) | ヘテロアリール(アルキル)ジチオカルバメート化合物、その調製方法及び使用 | |
CN1072213C (zh) | 胍衍生物的制备方法及其中间体 | |
JP7085697B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
CN110183386B (zh) | 地克珠利衍生物及其应用和含有该衍生物的杀菌剂 | |
WO2022202537A1 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
TWI621609B (zh) | 製備4-鹵烷基-3-巰基-取代之2-羥基苯甲酸衍生物 | |
JP7159485B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
JP7109684B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
WO2008117884A1 (ja) | トリクロロピリミジン化合物の製造方法 | |
JP7349551B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
JP6466107B2 (ja) | 4−フェニルチオ−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 | |
JP6479486B2 (ja) | 4−アルコキシ−5−(トリフルオロメチル)ピリミジン誘導体及びその製造方法 | |
JP7230274B2 (ja) | 含フッ素ピリミジン化合物およびその製造方法 | |
JP5147757B2 (ja) | 1,3−ジ置換2−ニトログアニジンを製造するための方法 | |
Kukaniev et al. | Reactions of thioamides and alkali metal salts of dithiocarbamates with 2-bromo-7-methyl-5-oxo-5H-1, 3, 4-thiazolo [3, 2-a] pyrimidine and antimicrobial activity of products | |
WO2023068200A1 (ja) | 含フッ素ピラゾール化合物およびその製造方法 | |
KR20150032537A (ko) | 2,2-디플루오로에틸아민의 알킬화에 의한 2,2-디플루오로에틸아민 유도체의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20880783 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021553690 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17768556 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020880783 Country of ref document: EP Effective date: 20220601 |